Interplay between impaired calcium regulation and insulin signaling abnormalities in diabetic cardiomyopathy

Nature Clinical Practice Cardiovascular Medicine

Volumn 5, Issue 11, 2008, Pages 715-724

  Lebeche, Djamel ^a   Davidoff, Amy J ^b   Hajjar, Roger J ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEW ENGLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; ATRIAL NATRIURETIC FACTOR; CALCIUM CHANNEL L TYPE; CALCIUM ION; GLUCOSE; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; MYOSIN ADENOSINE TRIPHOSPHATASE; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; N ACETYLGLUCOSAMINE; PARVOVIRUS VECTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLAMBAN; POTASSIUM ION; PROTEIN KINASE C; RYANODINE RECEPTOR; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM ION;

CALCIUM CURRENT; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CARDIOMYOPATHY; CAUSE OF DEATH; CYTOLOGY; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EXCITATION CONTRACTION COUPLING; GENE THERAPY; GLUCOSE METABOLISM; HEART ASSIST DEVICE; HEART FAILURE; HEART MUSCLE CELL; HEART VENTRICLE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOPHYSIOLOGY; POTASSIUM CURRENT; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; SODIUM CALCIUM EXCHANGE; SYSTOLIC DYSFUNCTION;

ADULT; AGED; BLOOD GLUCOSE; CALCIUM SIGNALING; CARDIOMYOPATHIES; DIABETES COMPLICATIONS; HUMANS; INSULIN; INSULIN RESISTANCE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIUM; VENTRICULAR FUNCTION; YOUNG ADULT;

EID: 55149083279     PISSN: 17434297     EISSN: 17434300     Source Type: Journal    
DOI: 10.1038/ncpcardio1347     Document Type: Review

References (72)

1. International Diabetes Federation (online 2006) Diabetes Atlas, 3rd edition [http://www.eatlas.idf.org/media]
2. Sowers J R et al. (2001) Diabetes, hypertension, and cardiovascular disease: An update. Hypertension 7: 1053-1059
3. Boudina S and Abel ED (2007) Diabetic cardiomyopathy revisited. Circulation 115: 3213-3223
4. Fox CS et al. (2007) Increasing cardiovascular disease burden due to diabetes mellitus: The Framingham Heart Study. Circulation 115: 1544-1550
5. Rubler S et al. (1972) A new type of cardlomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30: 595-602
6. Gaiderisi M et al. (1991) Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol 68: 85-89
7. Severson D (2004) Diabetic cardiomyopathy: Recent evidence from mouse models of type 1 and type 2 diabetes. Can J Physiol Pharmacol 82: 813-823
8. Poomima IG net al. (2006) Diabetic cardiomyopathy: The search for a unifying hypothesis. Circ Res 98: 596-605
9. Witteles RM and Fowler MB (2008) Insuhn-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options. J Am Coll Cardiol 51: 93-102
10. An D and Rodrigues B (2006) Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 291: H1489-H1506
11. Dillmann W (1980) Diabetes mellitus induces changes in cardiac myosin of the rat. Diabetes 29: 579-582
12. Malhotra A et al. (1995) Molecular biology of protein kinase C signaling in cardiac myocytes. Mol Cell Biochem 151: 165-172
13. Yaras N et al. (2007) Restoration of diabetes-induced abnormal local Ca2+ release in cardiornyocytes by angiotensin II receptor blockade. Am J Physiol Heart Circ Physiol 292: H912-H920
14. Ren J and Davidoff AJ (1997) Diabetes rapidly induces contractile dysfunctions in isolated ventricular myocytes. Am J Physiol 272 H148-H158
15. Ishikawa T et al. (1999) Alterations in contractile properties and Ca2+ handling in streptozotocin-induced diabetic rat myocardium. Am J Physiol Heart Circ Physiol 277: H2185-H2194
16. Jourdon P and Feuvray D (1993) Calcium and potassium currents in ventricular myocytes isolated from diabetic rats. J Physiol 470 411-429
17. Penpargkul S et al. (1981) Depressed cardiac sarcoplasmic reticulum function from diabetic rats. J Mol Cell Cardiol 13 303-309
18. Chattou S et al. (1999) Decrease in sodium-calcium exchange and calcium currents in diabetic rat ventricular myocytes. Acta Physiol Scanda 166: 137-144
19. 2+ homeostasis in rat heart. Diabetes 54: 3082-3088
20. Gando S et al. (1997) Impaired contractile response to beta adrenoceptor stimulation in diabetic rat hearts: Alterations in beta adrenoceptors-G protein-adenylate cyclase system and phospholamban phosphorylation. J Pharmacol Exp Ther 282: 475-84
21. Zhong Y et al. (2001) Altered SR protein expression associated with contractile dysfunction in diabetic rat hearts. Am J Physiol Heart Circ Physiol 281: H1137-H1147
22. + currents in rat ventricular myocytes. Circ Res 74: 620-628
23. 2+ currents in ventricular myocytes from rats with chronic diabetes. Am J Physiol 269: H1288-H1296
24. 2+ current in cardiac myocytes of type 1 diabetic Akita mice due to reduced phosphatidylinositol 3-kinase signaling. Diabetes 56: 2780-2789
25. Wold LE et al. (2005) Impaired SERCA function contributes to cardiomyocyte dysfunction in insulin resistant rats. J Mol Cell Cardiol 39: 297-307
26. Belke DD et al. (2004) Decreased sarcoplasmic reticulum activity and contractility in diabetic db/db mouse heart. Diabetes 53: 3201-3208
27. (2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy. Diabetes 51: 1166-1171
28. del Monte F et al. (1999) Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a. Circulation 100: 2308-2311
29. Hattori Y et al. (2000) Diminished function and expression of the cardiac Na+-Ca2+ exchanger in diabetic rats: Implication in Ca2+ overload. J Physiol 527: 85-94
30. i transient decrease in cardiomyopathy of db/db type 2 diabetic mice. Diabetes 55: 608-615
31. 2+ exchanger activity in the diabetic heart. Cardiovasc Res 34: 129-136
32. 2+-exchanger overexpression on excitation-contraction coupling in adult rabbit ventricular myocytes. J Mol Cell Cardiol 34: 389-400
33. Dutta K et al. (2002) Depressed PKA activity contributes to impaired SERCA function and is linked to the pathogenesis of glucose-induced cardiomyopathy. J Mol Cell Cardiol 34: 985-996
34. Marks AR (2001) Ryanodine receptors/calcium release channels in heart failure and sudden cardiac death. J Mol Cell Cardiol 33: 615-624
35. Boudina S and Abel ED (2006) Mitochondrial uncoupling: A key contributor to reduced cardiac efficiency in diabetes. Physiology 21: 250-258
36. Nisoli E et al. (2007). Defective mitochondrial biogenesis: A hallmark of the high cardiovascular risk in the metabolic syndrome? Circ Res 100: 795-806
37. 2+ signaling. Physiology 23: 84-94
38. Malhotra A and Sanghi V (1997) Regulation of contractile proteins in diabetic heart. Cardiovasc Res 34: 34-40
39. Jweied EE et al. (2005) Depressed cardiac myofilament function in human diabetes mellitus. Am J Physiol Heart Circ Physiol 289 H2478-H2483
40. + currents by angiotensin and endothelin. Am J Physiol Heart Circ Physiol 284: H1168-H1181
41. Akella AB et al. (1995) Diminished Ca2+ sensitivity of skinned cardiac muscle contractility coincident with troponin T-band shifts in the diabetic rat. Circ Res 76: 600-606
42. Susic D et al. (2004) Collagen cross-link breakers: A beginning of a new era in the treatment of cardiovascular changes associated with aging, diabetes, and hypertension. Curr Drug Targets Cardiovasc Haematol Disord 4:97-101
43. Bidasee KR et al. (2004) Diabetes increases formation of advanced glycation end products on sarco(endo)plasmic reticulum Ca2+-ATPase. Diabetes 53: 463-473
44. Bidasee KR et al. (2003) Chronic diabetes increases advanced glycation end products on cardiac ryanodine receptors/calcium-release channels. Diabetes 52: 1825-1836
45. F-dsulöp N et al. (2007) Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system. Cardiovasc Res 73: 288-297
46. Fein FS et al. (1981) Reversibility of diabetic cardiomyopathy with insulin in rats. Circ Res 49: 1251-1261
47. Abel ED (2005) Myocardial insulin resistance and cardiac complications of diabetes. Curr Dnig Targets Immune Endocr Metabol Disord 5 219-226
48. Davidoff AJ (2006) Convergence of glucose- and fatty acid-induced abnormal myocardial excitation-contraction coupling and insulin signalling. Clin Exp Pharmacol Physiol 33: 152-158
49. Ouwen DM and Diamant M (2007) Myocardial insulin action and the contribution of insulin resistance to the pathogenesis of diabetic cardiomyopathy. Arch Physiol Biochem 113:76-86
50. Morisco C et al. (2006) Insulin resistance and cardiovascular risk: New insights from molecular and cellular biology. Trends Cardiovasc Med. 16: 183-188
51. Belke DD et al. (2002) Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J Clin Invest 109: 629-639
52. McQueen AP et al. (2005) Contractile dysfunction in hypertrophied hearts with deficient insulin receptor signaling: Possible role of reduced capillary density. J Mol Cell Cardiol 39: 882-892
53. Krook A et al. (2000) Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. Diabetes 49: 284-292
54. Kolter T et al. (1997) Molecular analysis of insulin resistance in isolated ventricular cardiomyocytes of obese Zucker rats. Am J Physiol Endocrinol Metab 273: E59-E67
55. Petersen KF and Shulman GI (2006) Etiology of insulin resistance. Am J Med 119 (Suppl 1): S10-S16
56. O'Neill BT et al. (2007) A conserved role for phosphatidylinositol 3-kinase but not Akt signaling in mitochondrial adaptations that accompany physiological cardiac hypertrophy. Cell Metab 6: 294-306
57. Hart GW et al. (2007) Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 446: 1017-1022
58. Sakata S et al. (2006) Mechanical and metabolic rescue in a type II diabetes model of cardiomyopathy by targeted gene transfer. Mol Ther 13: 987-996
59. 2+-ATPases in muscle and heart. J Biol Chem 272: 23696-23702
60. Ouwens DM et al. (2005) Cardiac dysfunction induced by high-fat diet is associated with altered myocardial insulin signalling in rats. Diabetologia 48: 1229-1237
61. Davidoff AJ et al. (2004) Diabetic cardiomyocyte dysfunction and myocyte insulin resistance: Role of glucose-induced PKC activity. Mol Cell Biochem 262: 155-163
62. Yu J et al. (2006) Insulin improves cardiomyocyte contractile function through enhancement of SERCA2a activity in simulated ischemia/ reperfusion. Acta Pharmacol Sin 27: 919-926
63. Michael A et al. (2004) Glycogen synthase kinase-3β regulates growth, calcium homeostasis, and diastolic function in the heart. J Biol Chem 279: 21383-21393
64. Von Lewinski D et al. (2005) Insulin causes [Ca2+]i-dependent and [Ca2+]i-independent positive inotropic effects in failing human myocardium. Circulation 111: 2588-2595
65. Jo SH et al. (2002) Phosphatidylinositol 3-kinase functionally compartmentalizes the concurrent G(s) signaling during β2-adrenergic stimulation. Circ Res 91: 46-53
66. Condorelli G et al. (2002) Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc Natl Acad Sci USA 99: 12333-12338
67. Crackower MA et al. (2002) Regulation of myocardial contractility and cell size by distinct P13K-PTEN signaling pathways. Cell 110: 737-749
68. Kerfant BG et al. (2005) Cardiac sarcoplasmic reticulum calcium release and load are enhanced by subcellular cAMP elevations in PI3Kgamma-deficient mice. Circ Res 96: 1079-1086
69. Rota M et al. (2005) Nuclear targeting of Akt enhances ventricular function and myocyte contractility. Circ Res 97: 1332-1341
70. Kim YK et al. (2003) Mechanism of enhanced cardiac function in mice with hypertrophy induced by overexpressed Akt. J Biol Chem 278: 47622-47628
71. 2+ currents via increased PI3Kalpha/PKB signaling. Circ Res 98: 1390-1397
72. Paternostro G et al. (1999) Insulin resistance in patients with cardiac hypertrophy. Cardiovasc Res 42: 246-253